Skip to content

Clinical trials

Phase 2 Ovarian Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Country / region: Australia Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20041
20062
20071
20083
20102
20121
20132
20151
20171
20182
20191
20201
20212
20221
20233
20244
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting8
Active, not recruiting5
Terminated3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
AbbVie3
Gynecologic Oncology Group3
Hoffmann-La Roche2
Incyte Corporation2
AbbVie (prior sponsor, Abbott)1
Bayer1
Bristol-Myers Squibb1
Children's Oncology Group1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms36
Fallopian Tube Neoplasms7
Carcinoma, Ovarian Epithelial6
Breast Neoplasms5
Pancreatic Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms4
Endometrial Neoplasms4
Head and Neck Neoplasms4
Melanoma4

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.